PHS
TDC icon

PFM Health Sciences’s Teradata TDC Stock Holding History

PFM Health Sciences’s Portfolio TDC Stock Details TDC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-674,137
Closed -$37.4M – 73
2013
Q3 		$37.4M Buy
+674,137
New +$39.6M 0.9% 34

Other funds holding TDC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
CRM
Cramer Rosenthal McGlynn Stamford, Connecticut $1.36B AUM 31.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

PFM Health Sciences's TDC Position: Q4 2013 in Review

PFM Health Sciences sold out of Teradata (TDC) in Q4 2013, closing a stake of 674,137 shares — an estimated $37.4M sold.

PFM Health Sciences first reported a position in TDC in Q3 2013 and held it in 1 quarter. The position peaked at $37.4M in Q3 2013. 440 funds tracked by Wall St. Rank hold TDC as of Q4 2013.

  • PFM Health Sciences reported no remaining Teradata position as of Q4 2013 after selling out during the quarter.
  • PFM Health Sciences sold 674,137 Teradata shares in Q4 2013, an estimated $37.4M.
  • PFM Health Sciences first reported a position in Teradata in Q3 2013 and held it in 1 quarter.
  • PFM Health Sciences's Teradata position peaked at $37.4M in Q3 2013.
  • 440 funds tracked by Wall St. Rank held Teradata as of Q4 2013.

Based on PFM Health Sciences's 13F filing for Q4 2013, filed 14 Feb 2014.